ZACKSยท2025-06-03 15:06Market Overview - After months of volatility due to geopolitical uncertainty and tariff policies, the market is experiencing a bullish momentum as tariff policies moderate and economic growth forecasts rebound [1] - Investors are embracing risk again, driven by AI-driven productivity gains [1] Company Highlights AppLovin (APP) - AppLovin has emerged as a top-ranked stock with strong performance, driven by consistent earnings growth and attractive valuation [3] - Consensus estimates for FY25 have increased by 22%, and FY26 estimates have risen by 26.4%, reflecting renewed confidence in long-term profit growth [4] - The stock is showing technical momentum, currently consolidating below a key resistance level at $400, with potential for a breakout to new all-time highs [5] Hims & Hers Health (HIMS) - Hims & Hers Health has rapidly grown in the digital health sector, particularly in telemedicine and wellness products, with significant expansion into the weight-loss treatment market [7] - The company is projected to grow earnings at a compound annual rate of 36.5% over the next three to five years, with current-quarter EPS estimates up by 21.4% [8] - The stock is in breakout mode, having recently surpassed key resistance levels, indicating potential for further upside [9] Meta Platforms (META) - Meta Platforms continues to innovate while maintaining its dominance in the digital platform space, with over 3 billion daily active users [12] - The stock recently broke out following positive AI news, including the launch of an AI-powered advertising platform that automates campaign management [13] - Despite a Zacks Rank of 3 (Hold), Meta is projected to grow earnings at a robust annual rate of 16.1% over the next three to five years [14] Investment Considerations - Meta, AppLovin, and Hims & Hers Health present a compelling mix of strong fundamentals, breakout technical setups, and exposure to long-term themes such as AI, digital advertising, and telemedicine [15]